Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
Biomarkers for multiple sclerosis.
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Substance Name: Riluzole
Assessing upper limb function in multiple sclerosis.
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up.
Selective depression of low-release probability excitatory synapses by sodium channel blockers.
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.
Prediction of response to interferon therapy in multiple sclerosis.
Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis.
The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.
Id1 Expression Promotes T Regulatory Cell Differentiation by Facilitating TCR Costimulation.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
[HTLV-1-associated myelopathy/tropical spastic paraparesis : A differential diagnosis in multiple sclerosis.]
Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis.
Differential Contributions of Alcohol and Nicotine-Derived Nitrosamine Ketone (NNK) to White Matter Pathology in the Adolescent Rat Brain.
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge.
Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis (DES)
Secukinumab (AIN457) showed superiority over Enbrel® in clearing skin, according to pivotal Novartis Phase III psoriasis results at EADV
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review.
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.

Pages